Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple Sclerosis

Conditions:   Relapsing Remitting Multiple Sclerosis;   Optic Neuropathy;   Optic; Neuritis, With Demyelination Interventions:   Drug: CNM-Au8;   Drug: Placebo Sponsors:   Clene Nanomedicine;   Clene Australia Pty Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials